Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
Korean Journal of Radiology
;
: 175-178, 2008.
Article
Dans Anglais
| WPRIM
| ID: wpr-82034
ABSTRACT
Lansoprazole is an acid proton-pump inhibiting drug that is used for the treatment of duodenal or gastric ulcers, H. pylori infection, gastroesophageal reflux disease or Zollinger-Ellison syndrome. Although lansoprazole is well known for its gastrointestinal and dermatologic adverse effects, mild pulmonary symptoms are also known to develop from taking this drug. There have been no reports about lansoprazole-induced interstitial lung disease. We report here a case of lansoprazole-induced interstitial lung disease that developed in a 66-year-old man.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Biopsie
/
Reflux gastro-oesophagien
/
Tomodensitométrie
/
Pneumopathies interstitielles
/
Chirurgie thoracique vidéoassistée
/
(Pyridin-2-ylméthyl)sulfinyl-1H-benzimidazoles
/
Poumon
/
Antiulcéreux
Limites du sujet:
Adulte très âgé
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Korean Journal of Radiology
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS